By proceeding, you agree to our Terms of Use and Privacy Policy.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
16-18 March 2022
IO360°convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.
Event Ended
USA
Paid
New York
18-21 April 2022
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain. If you are involved in vaccines or new to it because of t
17-19 May 2022
Turbocharge the Development of Best-In-Class Treg-Directed Therapies, Maximizing Stability and Function to Deliver Safe, Scalable and Efficacious Therapies Globally As Biopharma turn their focus to autoimmune drug development, there has been an explo
Boston
07-08 September 2022
The Disease Prevention & Control Summit is more than just an event, it is a chance to partner, learn, connect, and make great strides towards preventing and combating infectious disease outbreaks of today and tomorrow.
Fort Washington
19-22 September 2022
Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC
03-06 April 2023
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain If you are involved in vaccines or new to it because of th
WASHINGTON D.C
30-01 June 2023
Join us at the 5th Treg Summit, where we will be discussing the latest advancements in IL-2 and CAR-Treg therapies, and how advanced engineering and product design can enhance their tissue specificity, durability, stability, and safety, thus accelera
29-01 September 2023
The Vice President of Discovery and Translational Research at Deverra Therapeutics, Erika von Euw, highly recommends attending the upcoming CAR-TCR Summit if you work in cell therapy. Last year marked a significant milestone in the field of cell ther